Mayo Clinic | Strategic Alliance Partners

Latest from Mayo Clinic


Dr. Kasi on the Rising Incidence of CRC

January 24, 2019

Pashtoon M. Kasi, MD, MBBS, MS, an assistant professor of Oncology and senior associate consultant in the Division of Hematology/Oncology, Mayo Clinic, discusses the rising incidence of colorectal cancer (CRC).

Dr. Goetz on Survival Data With CDK4/6 Inhibitors in Breast Cancer

January 23, 2019

Matthew P. Goetz, MD, chair of the Breast Cancer Disease-Oriented Group and co-leader of the Women’s Cancer Center at the Mayo Clinic, discusses survival data with CDK4/6 inhibitors in patients with hormone receptor-positive breast cancer.

MyDRUG Evaluates Targeted Agents in Multiple Myeloma

January 16, 2019

Investigators are taking a personalized approach to treating patients with multiple myeloma by introducing novel agents in combination with backbone chemotherapies, based on patients’ individual genetic profiles.

Dr. Kasi Discusses Treatment Approaches for mCRC

January 10, 2019

Pashtoon M. Kasi, MD, MBBS, MS, an assistant professor of Oncology and senior associate consultant in the Division of Hematology/Oncology, Mayo Clinic, discusses treatment approaches for patients with metastatic colorectal cancer.

Dr. O'Sullivan Discusses the Future of HER2+ Breast Cancer Treatment

November 27, 2018

Ciara O'Sullivan, MB, BCh, senior associate consultant, assistant professor of oncology, Division of Medical Oncology, Department of Oncology, Mayo Clinic, discusses the future for HER2-positive breast cancer treatment.